Momenta Pharmaceuticals Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Momenta Pharmaceuticals Inc.

MNTA 52.48

0.0%

Oct 2 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: semi_infinite	12/6/2010 10:55:07 AM
	Read Replies (1) of 3027

If "identical", then why would T-lovenox be in bureaucratic limbo? english.themarker.com >>>>>> Bill Marth, CEO of Teva North America, said the company held a meeting with the FDA over its generic Lovenox product and proved that Teva's version is identical to the original developed by Sanofi-Avenis and does not copy the Momenta method. He added that it will be disappointing if Teva doesn't receive approval for the drug before the end of the year. >>>>>>

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next